Browse > Article

The Change of HBV DNA Titer after Hepatic Resection in Hepatitis B Patients with Hepatocelluar Carcinoma  

Lee, Hae-Won (Department of Surgery, Seoul National University College of Medicine)
Suh, Kyung-Suk (Department of Surgery, Seoul National University College of Medicine)
Kim, Joo-Hyun (Department of Surgery, Seoul National University College of Medicine)
Shin, Woo-Young (Department of Surgery, Seoul National University College of Medicine)
Yi, Nam-Joon (Department of Surgery, Seoul National University College of Medicine)
Lee, Kuhn-Uk (Department of Surgery, Seoul National University College of Medicine)
Publication Information
Annals of Hepato-Biliary-Pancreatic Surgery / v.14, no.1, 2010 , pp. 16-24 More about this Journal
Abstract
Purpose: Reactivation of hepatitis B virus (HBV) replication after hepatic resection might be a significant risk factor for prognosis in patients with chronic hepatitis B. The purpose of the present study was to investigate the changing pattern of serum HBV DNA titer after hepatic resection and to assess the incidence of reactivation of HBV replication. Methods: Among HBV-positive patients who underwent hepatic resection for hepatocellular carcinoma, thirty-six patients with preoperative serum HBV DNA titer ${\geq}$3 $log_{10}$copies/mL were enrolled. Serum DNA titers were examined before the operation, on the second and seventh postoperative days, and one month after the operation. Results: The serum DNA titer decreased on the second postoperative day (p=0.078). The DNA level, however, had substantially returned to preoperative values by the seventh postoperative day (p<0.001). For most patients, the postoperative DNA titer reached its zenith on the seventh postoperative day or one month after the operation. The zenith level was higher (by 0.49${\pm}$0.25 log10copies/mL) than preoperative levels although this difference just missed significance (p=0.068). Although postoperative reactivation of HBV replication emerged in 6 patients, only one of those patients developed postoperative hepatitis. Overall, four patients developed postoperative hepatitis and all of them had high postoperative HBV DNA levels (over 6 log10copies/mL). Conclusion: Although serum HBV DNA titers tended to increase postoperatively, routine antiviral therapy might be unnecessary because of the low incidence of postoperative hepatitis. High postoperative DNA levels, however, might be a risk factor for hepatitis, and postoperative follow-up of serum HBV DNA levels might be necessary in HBV-positive patients with hepatic resection.
Keywords
DNA; Hepatitis B; Carcinoma; Hepatocellular; Hepatectomy; DNA replication;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wands JR, Chura CM, Roll FJ, Maddrey WC. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975;68:105- 112.
2 Hoofnagle JH, Dusheiko GM, Schafer DF, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982;96:447-449.   DOI   ScienceOn
3 Thung SN, Gerber MA, Klion F, Gilbert H. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med 1985;145:1313-1314.   DOI   ScienceOn
4 Pariente EA, Goudeau A, Dubois F, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci 1988; 33:1185-1191.   DOI   ScienceOn
5 Bird GL, Smith H, Portmann B, Alexander GJ, Williams R. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med 1989;73:895-902.
6 Lau JY, Lai CL, Lin HJ, et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 1989;73:911-917.
7 Flowers MA, Heathcote J, Wanless IR, et al. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy. Ann Intern Med 1990;112:381-382.   DOI   ScienceOn
8 Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991;100:182-188.   DOI
9 Yoshiba M, Sekiyama K, Sugata F, Okamoto H, Yamamoto K, Yotsumoto S. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 1992;37:1253-1259.   DOI   ScienceOn
10 Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 1991;13: 619-626.
11 O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992;14:104-111.   DOI   ScienceOn
12 Roche B, Samuel D. Evolving strategies to prevent HBV recurrence. Liver Transpl 2004;10(10 Suppl 2):S74-85.
13 Wilmore DW. Homeostasis: bodily changes in trauma and surgery. In: Sabiston DG Jr. Textbook of Surgery. 45th ed. Philadelphia: WB Saunders; 1997.55-67.
14 Villeneuve JP, Condreay LD, Willems B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000;31:207-210.   DOI   ScienceOn
15 Lo CM, Cheung ST, Lai CL, et al. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg 2001;233:276-281.   DOI   ScienceOn
16 Perrillo RP, Wright T, Rakela J, et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after transplantation for chronic hepatitis B. Hepatology 2001;33:424-432.   DOI   ScienceOn
17 Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001;34: 411-416.   DOI   ScienceOn
18 Fontana RJ, Hann HW, Perrillo RP, et al. Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology 2002;123:719-727.   DOI   ScienceOn
19 Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality, and prevalence worldwide. version 2.0 IARC Press. 2004.
20 Bronowicki JP, Boudjem K, Chone L, et al. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol 1996;24:293-300.   DOI   ScienceOn
21 Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocelluar carcinoma in 110 patients with cirrhosis. Ann Surg 2000;232:381-391.   DOI   ScienceOn
22 Song JW, Lee JG, Kim KS, Choi JS, Lee WJ, Kim BR. Combined hepatic resection and intraoperative radio-frequency ablation for multiple hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg 2005;9:150-155.
23 Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, hepatitis B virus, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004;96:1851-1856.   DOI   ScienceOn
24 Kubo S, Nishiguchi S, Hamba H, et al. Reactivation of viral replication after liver resection in patients infected with hepatitis B virus. Ann Surg 2001;233:139-145.   DOI   ScienceOn
25 Shuqun C, Mengchao W, Han C, et al. Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection. Hepatogastroenterology 2006;53:249-252.